This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Abstral 100 microgram sublingual tablets PA2288/004/002 Kyowa Kirin Holdings B.V. | Fentanyl |
| Abstral 400 microgram sublingual tablets PA2288/004/005 Kyowa Kirin Holdings B.V | Fentanyl |
| Calcium Resonium 99.934 % Powder for oral or rectal suspension PA0540/141/001 Sanofi-Aventis Ireland Limited T/A SANOFI | Calcium polystyrene sulphonate |
| Evorel 50 micrograms per 24 hours Transdermal Patch PA22668/008/001 Theramex Ireland Limited | Estradiol |
| Furosemide 20mg in 2ml Solution for Injection PA0073/059/004 Mercury Pharmaceuticals (Ireland) Ltd | Furosemide |
| Morphine Sulphate 30 mg/ml Solution for Injection PA0073/020/004 Mercury Pharmaceuticals (Ireland) Ltd | Morphine |
| Nyxoid 1.8 mg nasal spray, solution in single-dose container EU/1/17/1238/001 Mundipharma Corporation (Ireland) Limited | Naloxone |
| Retrovir 10 mg/ml IV concentrate for solution for infusion PA22575/001/003 ViiV Healthcare BV | Zidovudine |
| Tyvense 70 mg Capsules, Hard PA23211/005/006 Takeda Pharmaceuticals International AG Ireland Branch | Lisdexamfetamine |
| Zypadhera Powder and solvent for prolonged-release suspension for injection 300mg vial presentation EU/1/08/479/002 Eli Lilly Nederland B.V | Olanzapine |
| Hypnovel 10mg/2ml Solution for Injection PA2239/007/001 CHEPLAPHARM Arzneimittel GmbH | Midazolam |
| Raporsin 4 mg prolonged-release tablets PA2315/005/002 Accord Healthcare Ireland Ltd | Doxazosin |
| Minims Cyclopentolate Hydrochloride 1% w/v Eye Drops, solution PA23259/011/001 Bausch + Lomb Ireland Limited | Cyclopentolate |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Actiq 400 micrograms compressed lozenge with integral oromucosal applicator PA0749/195/002 Teva Pharma B.V. | Fentanyl |
| Azactam 1 g Powder for Solution for Injection or Infusion
PA0002/052/002
Bristol-Myers Squibb Pharmaceuticals uc | Aztreonam |
| Azactam 2 g Powder for Solution for Injection or Infusion
PA0002/052/003
Bristol-Myers Squibb Pharmaceuticals uc | Aztreonam |
| Finasteride 1mg film-coated tablets
PA22753/002/001
Careforsons Ireland Limited | Finasteride |
| Geroquel 25 mg film-coated tablets
PA0577/090/001
McDermott Laboratories Ltd., T/A Gerard Laboratories | Quetiapine |
| Moviprep Orange, powder for oral solution
PA1336/001/002
Norgine B.V. | Macrogol 3350 & Sodium sulfate anhydrous & Sodium chloride & Potassium chloride & Ascorbic acid & Sodium ascorbate |
| Moviprep, powder for oral solution PA1336/001/001 Norgine B.V. | Macrogol 3350 & Sodium sulfate anhydrous & Sodium chloride & Potassium chloride & Ascorbic acid & Sodium ascorbate |
| Roaccutane 10 mg soft capsules
PA2307/007/001
Roche Products (Ireland) | Isotretinoin |
| Valsartan / Hydrochlorothiazide Teva 160 mg/25 mg Film-coated tablets
PA0749/047/002
Teva Pharma B.V. | Valsartan & hydrochlorothiazide |
| Zypadhera Powder and solvent for prolonged-release suspension for injection
405mg vial presentation
EU/1/08/479/003
Cheplapharm Registration GmbH | Olanzapine |
| Zypadhera Powder and solvent for prolonged-release suspension for injection
210mg vial presentation
EU/1/08/479/001
Cheplapharm Registration GmbH | Olanzapine |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.